Article Information
History
- May 31, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Katherine N. Theken, PharmD, PhD1,2,*,
- Soumita Ghosh, PhD1,
- Carsten Skarke, MD1,3,
- Susanne Fries, MD1,
- Nicholas F. Lahens, PhD1,
- Dimitra Sarantopoulou, MS1,4,
- Gregory R. Grant, PhD1,5,
- Garret A. FitzGerald, MD1,3 and
- Tilo Grosser, MD1,3,6,*
- 1Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
- 2Department of Oral and Maxillofacial Surgery and Pharmacology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States
- 3Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States
- 4National Institute on Aging, National Institutes of Health, Baltimore, MD, United States
- 5Department of Genetics, University of Pennsylvania, Philadelphia, PA, United States
- 6Department of Translational Pharmacology, EWL School of Medicine, Bielefeld University, Bielefeld, Germany
- ↵*Corresponding Authors:
Katherine N. Theken, PharmD, PhD, Department of Oral and Maxillofacial Surgery and Pharmacology, School of Dental Medicine, University of Pennsylvania, 240 S 40th St, Room 531 Levy, Philadelphia, PA 19104, Phone: +1 215 898-7470, Email: ktheken{at}pennmedicine.upenn.edu, Tilo Grosser, MD, Department of Translational Pharmacology, EWL School of Medicine, Bielefeld University, Universitätsstrasse 25, Bielefeld, Germany, Phone: +49 521 106-86800, Email: tilo.grosser{at}uni-bielefeld.de
Posted May 31, 2024.
Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response to Celecoxib and Naproxen
